Medicine and Dentistry
Acute Pulmonary Embolism
38%
All Cause Mortality
13%
Anemia
9%
Angioplasty
13%
Anticoagulant Therapy
24%
Anticoagulation
23%
Atrial Fibrillation
6%
Bleeding
14%
Blood Clot Lysis
8%
Cardiovascular Disease
9%
Chronic Thromboembolic Pulmonary Hypertension
33%
Cohort Analysis
8%
Comorbidity
8%
COVID-19
23%
COVID-19 Vaccine
6%
Decision Making
9%
Deep Vein Thrombosis
31%
Demography
6%
Direct Oral Anticoagulant
22%
Elderly Patient
6%
Glomerular Filtration Rate
6%
Hazard Ratio
18%
Heart Left Ventricle Failure
6%
Heart Right Ventricle Failure
11%
Hemodynamic
7%
Interventional Therapy
6%
Kidney Transplantation
6%
Low Molecular Weight Heparin
15%
Lymphocyte
6%
Major Bleeding
29%
Malignant Neoplasm
17%
Melanoma
6%
Meldonium
26%
Monocrotaline
8%
Myeloproliferative Disorder
8%
Occult Cancer
6%
Odds Ratio
14%
Prognostic Factor
6%
Pulmonary Embolism
57%
Pulmonary Hypertension
12%
Radical Surgery
6%
Recurrence Risk
11%
Recurrent Disease
35%
Right Ventricle
7%
Splenectomy
8%
Temporal Analysis
6%
Thrombophilia
13%
Thrombosis
8%
Venous Thromboembolism
100%
Vitamin K Antagonist
9%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
7%
All Cause Mortality
12%
Anemia
7%
Anticoagulant Agent
20%
Antivitamin K
9%
Atrial Fibrillation
6%
Bleeding
32%
Brain Natriuretic Peptide
7%
Cardiovascular Disease
9%
Chronic Kidney Failure
10%
Chronic Thromboembolic Pulmonary Hypertension
21%
Cohort Study
8%
Comorbidity
6%
Coronavirinae
6%
COVID-19 Vaccine
6%
Creatinine
5%
Deep Vein Thrombosis
27%
Direct Oral Anticoagulant
21%
Disease
11%
Functional Status
6%
Heart Left Ventricle Failure
6%
Heart Right Ventricle Failure
11%
Hemodialysis
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
5%
Low Molecular Weight Heparin
14%
Lung Cancer
6%
Lung Embolism
63%
Malignant Neoplasm
39%
Meldonium
26%
Monocrotaline
8%
Pulmonary Hypertension
10%
Recurrence Risk
11%
Recurrent Disease
36%
Rendu Osler Weber Disease
6%
Statin (Protein)
6%
Thrombophilia
13%
Thrombosis
8%
Upper Extremity Deep Vein Thrombosis
6%
Uterus Bleeding
6%
Venous Thromboembolism
92%
